BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/12/2016 1:04:00 PM | Browse: 310 | Download: 198
Publication Name World Journal of Gastroenterology
Manuscript ID 21231
Country of Manuscript Source China
Received
2015-07-01 18:27
Peer-Review Started
2015-07-04 23:03
To Make the First Decision
2015-08-26 15:11
Return for Revision
2015-09-01 15:22
Revised
2015-10-27 14:17
Second Decision
2015-12-22 12:39
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-12-30 17:28
Articles in Press
2015-12-30 17:28
Publication Fee Transferred
Edit the Manuscript by Language Editor
2016-01-27 11:37
Typeset the Manuscript
2016-03-03 15:21
Publish the Manuscript Online
2016-04-03 18:51
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA
Website http://www.wjgnet.com
Specialty Oncology
Manuscript Type Retrospective Study
Article Title Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma
Manuscript Source Unsolicited Manuscript
All Author List Jiang Li, Yu Hou, Xiao-Bei Cai and Bin Liu
Funding Agency and Grant Number
Correspondence To Bin Liu, MD, Department of Hepatobiliary Surgery, The First Affiliated Hospital of Kunming Medical University, No. 295 Xichang Road, Kunming 650032, Yunnan Province, China. 13888836057@163.com
Keywords Hepatocellular carcinoma; Survival; Hepatic resection; Sorafenib; Recurrence
Core Tip Barcelona Clinic Liver Cancer stage C patients with portal vein thrombus and Child-Pugh class A liver function who received sorafenib after surgical resection had significantly longer overall survival (37 mo vs 20 mo, p = 0.01) and significantly longer time to progression compared to patients who received only resection (29 mo vs 22 mo, p = 0.041). Our data suggested that better outcomes can be achieved with sorafenib after surgical resection, rather than sorafenib monotherapy.
Publish Date 2016-04-03 18:51
Citation Li J, Hou Y, Cai XB, Liu B. Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma. World J Gastroenterol 2016; 22(15): 4034-4040
Url http://www.wjgnet.com/1007-9327/full/v22/i15/4034.htm
DOI http://dx.doi.org/10.3748/wjg.v22.i15.4034
Full Article (PDF) WJG-22-4034.pdf
Full Article (Word) WJG-22-4034.doc
Revised Manuscript 21231-Review.doc
Peer-review Report 21231-Peer-review(s).pdf
Answering Reviewers 21231-Answering reviewers.pdf
Scientific Misconduct Check 21231-Scientific misconduct check.pdf
Scientific Editor Work List 21231-Scientific editor work list.pdf
Audio Core Tip 21231-Audio core tip.mp3
Biostatistics Review Certificate 21231-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 21231-Conflict-of-interest statement.pdf
Copyright License Agreement 21231-Copyright assignment.pdf
Data Sharing Statement 21231-Data sharing statement.pdf
Institutional Review Board Approval Form or Document 21231-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 21231-Language certificate.pdf